- Abiomed (NASDAQ:ABMD) is scheduled to announce Q1 earnings results on Thursday, August 6th, before market open.
- The consensus EPS Estimate is $0.32 (-68.0% Y/Y) and the consensus Revenue Estimate is $144.12M (-30.6% Y/Y).
- Over the last 2 years, ABMD has beaten EPS estimates 100% of the time and has beaten revenue estimates 38% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 3 downward.